IRIS
LEPEDDA, Antonio Junior
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.648
AS - Asia 2.802
EU - Europa 1.598
SA - Sud America 1.545
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 10.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.532
BR - Brasile 1.380
SG - Singapore 1.107
CN - Cina 839
UA - Ucraina 528
IT - Italia 291
HK - Hong Kong 269
VN - Vietnam 223
DE - Germania 213
FR - Francia 185
FI - Finlandia 92
GB - Regno Unito 82
SE - Svezia 65
AR - Argentina 64
TR - Turchia 57
CA - Canada 50
IQ - Iraq 49
IN - India 42
MX - Messico 36
BD - Bangladesh 35
ZA - Sudafrica 34
EC - Ecuador 32
RU - Federazione Russa 27
PK - Pakistan 26
UZ - Uzbekistan 23
MA - Marocco 21
KR - Corea 18
PL - Polonia 17
BE - Belgio 16
CO - Colombia 15
JP - Giappone 15
NL - Olanda 15
EU - Europa 13
ID - Indonesia 13
KE - Kenya 12
VE - Venezuela 12
NP - Nepal 10
PE - Perù 10
PY - Paraguay 10
CL - Cile 9
DZ - Algeria 9
ES - Italia 9
GR - Grecia 9
AU - Australia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
PH - Filippine 7
AT - Austria 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
TN - Tunisia 6
UY - Uruguay 6
IL - Israele 5
JO - Giordania 5
MY - Malesia 5
AL - Albania 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
IR - Iran 4
JM - Giamaica 4
KG - Kirghizistan 4
LT - Lituania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
EG - Egitto 3
GT - Guatemala 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
GD - Grenada 1
HU - Ungheria 1
Totale 10.701
Salva come PNG Salva come JPEG
Città #
Dallas 1.468
Singapore 610
Chandler 559
Jacksonville 322
San Jose 275
Hong Kong 268
Ashburn 240
Princeton 174
Beijing 173
New York 153
Nanjing 133
Sassari 123
São Paulo 110
Lauterbourg 86
Ann Arbor 82
Wilmington 79
Ho Chi Minh City 76
Dearborn 69
Nanchang 59
Shanghai 57
Los Angeles 52
Rio de Janeiro 48
Hanoi 47
Santa Clara 45
Boardman 44
Belo Horizonte 37
Tianjin 34
Changsha 32
Shenyang 32
Baghdad 30
Hebei 29
Woodbridge 28
Curitiba 26
Izmir 26
Campinas 23
Orem 23
Jiaxing 21
Johannesburg 21
Tashkent 21
Porto Alegre 20
Denver 19
Brasília 18
Buffalo 18
Council Bluffs 18
Seoul 18
Toronto 17
Warsaw 17
Brussels 16
Kunming 16
San Francisco 16
Zhengzhou 16
Hangzhou 15
London 15
Montreal 15
Mountain View 15
Da Nang 14
Salvador 14
Tokyo 14
Andover 13
Goiânia 13
Guarulhos 13
Haiphong 13
Ningbo 13
Ribeirão Preto 13
Stockholm 13
Villiers-sur-marne 13
Atlanta 12
Frankfurt am Main 12
Guayaquil 12
Norwalk 12
Fortaleza 11
Houston 11
Jinan 11
Manaus 11
Manchester 11
Nairobi 11
Brooklyn 10
Chennai 10
Dhaka 10
Guangzhou 10
Phoenix 10
Quito 10
Recife 10
Sorocaba 10
Amsterdam 9
Ankara 9
Bauru 9
Blumenau 9
Boston 9
Columbus 9
Helsinki 9
Mexico City 9
Munich 9
Santo André 9
Taubaté 9
Cagliari 8
Campo Grande 8
Casablanca 8
Juiz de Fora 8
Osasco 8
Totale 6.483
Salva come PNG Salva come JPEG
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 220
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 192
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 185
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 180
Apolipoprotein Profiles in Atherosclerotic Disease 179
Apolipoprotein profiles in atherosclerotic disease 171
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 160
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 159
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 158
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 158
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 154
Apolipoprotein Profiles in Atherosclerotic Disease 153
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 151
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth 151
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 150
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 150
Differential proteomic analysis of human atherosclerotic plaque extracts 146
Gradients in pore size enhance the osteogenic differentiation of human mesenchymal stromal cells in three-dimensional scaffolds 144
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 144
Apolipoprotein profiles in atherosclerotic disease 142
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 137
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 136
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 134
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 134
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 134
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 133
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 133
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 133
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 132
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 130
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 129
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 128
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 126
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 125
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 122
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 121
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 119
Identification and characterization of biomarkers in atherosclerosis and diabetes. 115
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 115
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 115
Tuning Cell Differentiation into a 3D Scaffold Presenting a Pore Shape Gradient for Osteochondral Regeneration 115
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 110
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 110
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 107
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 107
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 105
Urine bikunin as a marker of renal impairment in Fabry's disease 105
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 102
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 102
Influencing chondrogenic differentiation of human mesenchymal stromal cells in scaffolds displaying a structural gradient in pore size 101
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 100
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics 98
Protein oxidation in unstable plaque extracts from human carotid segments 98
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 98
Role of the small proteoglycan bikunin in human reproduction 98
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 97
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 95
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 94
Glycosaminoglycan content and distribution in human normal and varicose veins 93
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 93
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 93
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 92
Protein sulfhydryl-groups oxidation in stable and unstable human carotid plaques 91
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 90
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 90
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 89
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 88
Overview of Current Proteomic Approaches for Discovery of Vascular Biomarkers of Atherosclerosis 88
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 88
Effects of Acidic Polysaccharide-Enriched Extracts from Holothuria tubulosa on Two- and Three-Dimensional Invasive Breast Cancer Cell Models 84
Morphological and biochemical traits of target marine sponges 84
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 84
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 84
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 83
Glycosaminoglycan diversity in marine sponge extracellular matrix 83
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 83
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 82
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 79
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 79
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 77
Glycosaminoglycans and fabry’s disease 77
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 77
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 75
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 75
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 75
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 74
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 73
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 71
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 70
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 70
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 69
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 69
Molecular and pathobiological insights of bikunin/UTI in cancer 68
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 68
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 68
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 63
Urine bikunin and kidney involvement in Fabry disease 49
Evolutionary History of the Adult β- Globin Gene in Wild Sheep: First Sequences From the Argali (Ovis ammon) and the Urial (Ovis vignei) 21
Tunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small-Caliber Vascular Grafts: A Multi-Layered Strategy Combining Electrospinning and 4-Axis Printing 15
Emerging Insights into the Pathobiology of Acute Coronary Syndromes 9
Totale 10.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022477 53 3 3 11 10 2 25 31 63 34 56 186
2022/2023996 94 82 10 185 112 157 0 122 163 13 40 18
2023/2024359 49 25 7 12 83 76 14 8 9 11 36 29
2024/20252.733 19 23 155 43 114 67 205 464 969 454 155 65
2025/20264.191 178 916 768 605 461 240 440 132 172 180 71 28
Totale 10.796